The DOI matches its Crossref record.
Telomerase, Cell Immortality, and Cancer
Abstract
An important hallmark of cancer is aberrant growth control. Genetic changes that confer a growth advantage to the tumor cell are observed on numerous levels. Some of the best understood are mutations in proto-oncogenes and tumor suppressor genes that are linked to signal transduction pathways, cell cycle control, or cell-cell/cell-matrix interactions that regulate growth, movement, differentiation, survival, apoptosis, and genetic stability (Hartwell 1992; Weinberg 1992; Hunter 1993; Runger et al. 1994; Workman 1994). However, in addition to aberrant growth control, many cancer cells possess another important feature which distinguishes them from normal somatic cells: unlimited replicative capacity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A total lifetime loss of ~2-4 kb in average telomere length has been observed in human cells8-10.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [10]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 396
WRN at telomeres: implications for aging and cancer
Multani, A. S., & Chang, S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03397 · Cited by 95
Pendino, F., Flexor, M., Delhommeau, F., Selimoglu‐Buet, D., Lanotte, M., & Ségal-Bendirdjian, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111464998 · Cited by 101
The human Pif1 helicase, a potential Escherichia coli RecD homologue, inhibits telomerase activity
Zhang, D.-H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl029 · Cited by 97
Telomeres and telomerase: more than the end of the line
Pardue, M. L., & DeBaryshe, P. G. (1999) · Chromosoma · doi:10.1007/s004120050354 · Cited by 93
Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro
Li, H., Cao, Y., Berndt, M. C., Funder, J. W., & Liu, J. (1999) · Oncogene · doi:10.1038/sj.onc.1203061 · Cited by 92
Telomerase activation: one step on the road to cancer?
Greider, C. W. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01681-3 · Cited by 88
Self-citationEngelhardt, M. M., Albanell, J., Drullinsky, P. R., Han, W., Guillem, J. G., Scher, H. I., Reuter, V. E., & Moore, M. A. S. (1997) · PubMed · Cited by 88
Insertion of a Telomere Repeat Sequence into a Mammalian Gene Causes Chromosome Instability
Kilburn, A. E., Shea, M. J., Sargent, R. G., & Wilson, J. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.126-135.2001 · Cited by 87
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 88
Fossel, M. (1998) · JAMA · doi:10.1001/jama.279.21.1732 · Cited by 86
Yang, H., Kyo, S., Takatura, M., & Sun, L. (2001) · PubMed · Cited by 83
Immortalization and Transformation of Human Cells
Hahn, W. C. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15045-x · Cited by 84
Genomic organization of the Drosophila telomere retrotransposable elements
George, J. A., DeBaryshe, P. G., Traverse, K. L., Celniker, S. E., & Pardue, M.-L. (2006) · Genome Research · doi:10.1101/gr.5348806 · Cited by 87
Akiyama, M., Asai, O., Kuraishi, Y., Urashima, M., Hoshi, Y., Sakamaki, H., Yabe, H., Furukawa, T., Yamada, O., Mizoguchi, H., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702144 · Cited by 83
Lansdorp, P. M. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_2 · Cited by 82
Xu, D., Gruber, A., Björkholm, M., Peterson, C., & Pisa, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690480 · Cited by 82
Risk of prostate carcinoma death in patients with lymph node metastasis
Liang Cheng, C., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B. G., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1 · Cited by 359
Telomeres and Telomerase: A Simple Picture Becomes Complex
Lundblad, V., & Wright, W. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81358-6 · Cited by 78
Self-citationde Nigris, F., Cerutti, J. M., Morelli, C., Califano, D., Chiariotti, L., Viglietto, G., Santelli, G., & Fusco, A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600636 · Cited by 78
Liu, X., Zhou, Y., Lou, Y., & Zhong, H. (2015) · Gene · doi:10.1016/j.gene.2015.11.009 · Cited by 76
Kanzawa, T., Germano, I. M., Kondo, Y., Ito, H., Kyo, S., & Kondo, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601193 · Cited by 78
Akiyama, M., Yamada, O., Kanda, N., Akita, S., Kawano, T., Ohno, T., Mizoguchi, H., Eto, Y., Anderson, K. C., & Yamada, H. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00838-2 · Cited by 74
Structure and function of telomerase
Collins, K. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80013-5 · Cited by 75
Potent Inhibition of Human Telomerase by Nitrostyrene Derivatives
Kim, J., Kim, J. H., Lee, G. E., Lee, J. E., & Chung, I. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1117 · Cited by 75
Agents that target telomerase and telomeres
Raymond, É. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80068-1 · Cited by 74
Development of Retinoblastoma in the Absence of Telomerase Activity
Gupta, J., Han, L.-P., Wang, P., Gallie, B. L., & Bacchetti, S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1152 · Cited by 74
Self-citationMasutomi, K., & Hahn, W. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00703-6 · Cited by 75
Sonnenschein, C., Soto, A. M., Rangarajan, A., & Kulkarni, P. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9403-y · Cited by 72
Establishment and characterization of an immortalized human oviductal cell line
Lee, Y. L., Lee, C., Xu, J., Wang, Y., Tsao, S., & Yeung, W. S. B. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1046 · Cited by 72
Nuclear Accumulation of Globular Actin as a Cellular Senescence Marker
Kwak, I. H., Kim, H. S., Choi, O. R., Ryu, M. S., & Lim, I. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1856 · Cited by 70
Cutting Edge: Antigen-Dependent Regulation of Telomerase Activity in Murine T Cells
Hathcock, K. S., Weng, N., Merica, R. R., Jenkins, M. K., & Hodes, R. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5702 · Cited by 69
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70
Taylor, H. A., & Delany, M. E. (2000) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.2000.00540.x · Cited by 68
Steenbergen, R. D. M., Kramer, D., Meijer, C. J. L. M., Walboomers, J. M. M., Trott, D. A., Cuthbert, A. P., Newbold, R. F., Overkamp, W. J. I., Zdzienicka, M. Z., & Snijders, P. J. F. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.865 · Cited by 68
Theranostic applications of biomolecule‐responsive aggregation‐induced emission luminogens
Liao, Y., Peng, Z., Liu, X., Hu, Y., & Zhang, J. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230024 · Cited by 68
Brems-Eskildsen, A. S., Zieger, K., Toldbod, H., Holcomb, C. L., Higuchi, R., Mansilla, F., Munksgaard, P. P., Borre, M., Orntoft, T. F., & Dyrskjøt, L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-646 · Cited by 67
Functional genetics and experimental models of human cancer
Zhao, J. J., Roberts, T. M., & Hahn, W. C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.005 · Cited by 65
Telomeres, senescence, and hematopoietic stem cells
Zimmermann, S., & Martens, U. M. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0469-4 · Cited by 66
hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
de Wilde, J., Kooter, J. M., Overmeer, R., Claassen-Kramer, D., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-271 · Cited by 67
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
Chang, S. S., Khoo, C., & DePinho, R. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0374 · Cited by 64
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Telomeres in the chicken: genome stability and chromosome ends
Delany, M. E., Daniels, L. M., Swanberg, S. E., & Taylor, H. (2003) · Poultry Science · doi:10.1093/ps/82.6.917 · Cited by 62
Hiyama, E., Yamaoka, H., Matsunaga, T., Hayashi, Y., Ando, H., Suita, S., Horie, H., Kaneko, M., Sasaki, F., Hashizume, K., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602054 · Cited by 61
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia
Kubuki, Y., Suzuki, M., Sasaki, H., Toyama, T., Yamashita, K., Maeda, K., Ido, A., Matsuoka, H., Okayama, A., Nakanishi, T., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400018349 · Cited by 61
Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames
Choo, C.-K., Ling, M., Chan, K., Tsao, S., Zheng, Z., Zhang, D., Chan, L.-C., & Wong, Y.-C. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990801)40:3 · Cited by 60
Telomerase activation in cervical cancer.
Anderson, S., Shera, K. A., Ihle, J., Billman, L., Goff, B. A., Greer, B. E., Tamimi, H. K., McDougall, J. K., & Klingelhutz, A. J. (1997) · Europe PMC (PubMed Central) · Cited by 60
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8 · Cited by 147
Self-citationSmall-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death
Song, J. H., Kang, H.-J., Luevano, L. A., Gokhale, V. M., Wu, K., Pandey, R., Chow, H. ‐. S., Hurley, L. H., & Kraft, A. S. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.04.009 · Cited by 58
Measurement of Telomerase Activity in Dog Tumors
Yazawa, M., Okuda, M., Setoguchi, A., Nishimura, R., Sasaki, N., Hasegawa, A., WATARI, & Tsujimoto, H. (1999) · Journal of Veterinary Medical Science · doi:10.1292/jvms.61.1125 · Cited by 57
Telomerase activity and telomere length in benign and malignant human thyroid tissues
Kammori, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00547-4 · Cited by 57
Telomerase activity in plasma cell dyscrasias
Xu, D., Zheng, C., Bergenbrant, S., Holm, G., Björkholm, M., Yi, Q., & Gruber, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1655 · Cited by 56
Telomeres, hidden mosaicism, loss of heterozygosity, and complex genetic traits
Aviv, A., & Aviv, H. (1998) · Human Genetics · doi:10.1007/s004390050774 · Cited by 55
Kim, J. H., Kim, J. H., Lee, G. E., Kim, S. W., & Chung, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 54
Zhang, J., Lou, X., Jin, L., Zhou, R., Liu, S., Xu, N., & Liao, D. J. (2014) · Oncoscience · doi:10.18632/oncoscience.61 · Cited by 53
Glass, M. C., & Delany, M. E. (2016) · Poultry Science · doi:10.3382/ps/pev369 · Cited by 56
Sato, N., Maehara, N., Mizumoto, K., Nagai, E., Yasoshima, T., Hirata, K., & Tanaka, M. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3 · Cited by 51
Wang, Z., Kyo, S., Maida, Y., Takakura, M., Tanaka, M., Yatabe, N., Kanaya, T., Nakamura, M., Koike, K., Hisamoto, K., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205463 · Cited by 53
Adelstein, D. J., Rice, T. W., Becker, M., Larto, M. A., Kirby, T. J., Koka, A., Tefft, M., & Zuccaro, G. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970915)80:6 · Cited by 111
Telomeres, Telomerase and Chromosome Stability
Preston, R. J. (1997) · Radiation Research · doi:10.2307/3579618 · Cited by 53
Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA
Koga, S., Kondo, Y., Komata, T., & Kondo, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301449 · Cited by 51
Telomerase activity as a measure for monitoring radiocurability of tumor cells
Sawant, S. G., Grégoire, V., Dhar, S., Umbricht, C. B., Cvilic, S., Sukumar, S. V., & Pandita, T. K. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1047 · Cited by 50
Joo, O. H., Hande, M. P., Lansdorp, P. M., & Natarajan, A. T. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00321-7 · Cited by 50
Cancer vaccines: Accomplishments and challenges
Pejawar‐Gaddy, S., & Finn, O. J. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.010 · Cited by 49
Gan, L., Yang, X., Liu, Q., & Xu, H. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20585 · Cited by 49
New approaches for modelling cancer mechanisms in the mouse
Maddison, K., & Clarke, A. R. (2005) · The Journal of Pathology · doi:10.1002/path.1698 · Cited by 49
Telomerase activity in benign and malignant human thyroid tissues
Cheng, A.-J., Lin, J.-D., Chang, T. R., & Wang, T.-C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.363 · Cited by 48
Wu, X., Wu, J., Dai, J., Chen, B., Chen, Z., Wang, S., Wu, F., Lou, X., & Xia, F. (2020) · National Science Review · doi:10.1093/nsr/nwaa306 · Cited by 47
An analysis of the role of HnRNP C dysregulation in cancers
Mo, L., Meng, L., Huang, Z.-C., Yi, L., Yang, N., & Li, G. (2022) · Biomarker Research · doi:10.1186/s40364-022-00366-4 · Cited by 50
Huang, H., Huang, K.-F., Li, C.-L., Huang, Y.-Y., Chiang, Y.-H., Huang, F.-C., & Lin, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.072 · Cited by 48
Telomerase Activity in Human Benign Prostate Tissue and Prostatic Adenocarcinomas
Kallakury, B., Brien, T. P., Lowry, C. V., Muraca, P. J., Fisher, H. A. G., Kaufman, R. P., & Ross, J. S. (1997) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199708000-00003 · Cited by 45
BRD4 inhibitors block telomere elongation
Wang, S., Pike, A. M., Lee, S. S., Strong, M. A., Connelly, C. J., & Greider, C. W. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx561 · Cited by 45
Self-citationde Nigris, F., Cerutti, J. M., Morelli, C., Califano, D., Chiariotti, L., Viglietto, G., Santelli, G., & Fusco, A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600156 · Cited by 45
Akiyama, M., Horiguchi‐Yamada, J., Saito, S., Hoshi, Y., Yamada, O., Mizoguchi, H., & Yamada, H. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00365-7 · Cited by 45
Human lymphocyte telomerase is genetically regulated
Kosciolek, B. A., & Rowley, P. T. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2 · Cited by 42
Yaar, M., & Eller, M. S. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.11.1429 · Cited by 43
Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage
Kim, B.-H., Sung, S.-R., Choi, E.-H., Kim, Y.-I., Kim, K.-J., Dong, S.-H., Kim, H.-J., Chang, Y.-W., Lee, J.-I., & Chang, R. (2000) · Experimental & Molecular Medicine · doi:10.1038/emm.2000.6 · Cited by 42
Onitake, Y., Hiyama, E., Kamei, N., Yamaoka, H., Sueda, T., & Hiyama, K. (2009) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2009.07.046 · Cited by 45
Brunsvig, P. F., Guren, T. K., Nyakas, M., Steinfeldt-Reisse, C., Rasch, W., Kyte, J. A., Juul, H. V., Aamdal, S., Gaudernack, G., & Inderberg, E. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572172 · Cited by 41
Utilization of ribonucleotides and RNA primers by Tetrahymena telomerase.
Collins, K., & Greider, C. W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00226.x · Cited by 41
Self-citationTelomerase as a therapeutic target in glioblastoma
Aquilanti, E., Kageler, L., Wen, P. Y., & Meyerson, M. M. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab203 · Cited by 41
Krams, M., Claviez, A., Heidorn, K., Krupp, G., Parwaresch, R. M., Harms, D., & Rudolph, P. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63039-8 · Cited by 41
Ohuchida, K., Mizumoto, K., Ishikawa, N., Sato, N., Nagai, E., Yamaguchi, K., Takaishi, H., Ide, T., & Tanaka, M. (2004) · Cancer · doi:10.1002/cncr.20649 · Cited by 39
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
Sato, N., Mizumoto, K., Kusumoto, M., Nishio, S., Maehara, N., Urashima, T., Ogawa, T., & Tanaka, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1117 · Cited by 39
Nason-Burchenal, K., Maerz, W., Allopenna, J. J., Martin, P., Dmitrovsky, E., Albanell, J., & Moore, M. A. S. (1997) · Differentiation · doi:10.1046/j.1432-0436.1997.6150321.x · Cited by 39
Hanahan, D. (2000) · Nature · doi:10.1038/35020662 · Cited by 39
Futami, K., Ishikawa, Y., Goto, M., Furuichi, Y., & Sugimoto, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00778.x · Cited by 38
Promise and problems in relating cellular senescence in vitro to aging in vivo
Rubin, H. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00221-7 · Cited by 38
Wolf, N. S., & Pendergrass, W. (1999) · The Journals of Gerontology Series A · doi:10.1093/gerona/54.11.b502 · Cited by 37
Yuan, Z., Gault, E. A., Campo, M. S., & Nasir, L. (2010) · Journal of General Virology · doi:10.1099/vir.0.028191-0 · Cited by 37
Telomerase as an Important Target of Androgen Signaling Blockade for Prostate Cancer Treatment
Liu, S., Qi, Y., Ge, Y., Duplessis, T., Rowan, B. G., Ip, C. C. Y., Cheng, H., Rennie, P. S., Horikawa, I., Lustig, A. J., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0924 · Cited by 37
Chiu, C., Li, C.-H., Ung, M.-W., Fuh, T.-S., Chen, W.-L., & Fang, K. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.049 · Cited by 36
Lessons from Mice without Telomerase
Lansdorp, P. M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.309 · Cited by 36
Telomerase Activation inin Vitroandin VivoCervical Carcinogenesis
Zheng, P., Iwasaka, T., Yokoyama, M., Nakao, Y., Pater, A., & Sugimori, H. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4757 · Cited by 36
Lost in application: Measuring hypoxia for radiotherapy optimisation
Thiruthaneeswaran, N., Bibby, B. A. S., Yang, L., Hoskin, P., Bristow, R. G., Choudhury, A., & West, C. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.039 · Cited by 35
RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells
Lagah, S., Tan, I., Radhakrishnan, P., Hirst, R. A., Ward, J. H., O’Callaghan, C., Smith, S. J., Stevens, M. F. G., Grundy, R. G., & Rahman, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086187 · Cited by 35
Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay
Izutsu, T., Kudo, T., Sato, T., Nishiya, I., Ohyashiki, K., Mori, M., & Nakagawara, K. (1998) · Placenta · doi:10.1016/s0143-4004(98)90022-4 · Cited by 34
Yoo, J., Park, S. Y., Kang, S. J., Kim, B. K., Shim, S. I., & Kang, C. S. (2003) · Modern Pathology · doi:10.1097/01.mp.0000077517.44687.b6 · Cited by 35
Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
Janson, C. G., & During, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-32956-0 · Cited by 35
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Dillard, P., Köksal, H., Maggadottir, S. M., Winge-Main, A., Pollmann, S., Ménard, M., Myhre, M. R., Mælandsmo, G. M., Flørenes, V. A., Gaudernack, G., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.019 · Cited by 37
Hirao, S., SUGIYAMA, Y., Iwao, M., & Ishibashi, F. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90111 · Cited by 33
Metadata
- Authors
- Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., Piatyszek, M. A., Wright, W. E., & Shay, J. W.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1994-01-01
- Volume
- 59
- Issue
- 0
- Pages
- 307-315
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- OpenAlex
- W2064208421
- Cited by
- 396
- References
- 0
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 7 · 2022: 10 · 2021: 9 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 9 · 2016: 3 · 2015: 7 · 2014: 9 · 2013: 3 · 2012: 8
- Type
- posted content
- Language
- en
- Open access
- closed
- Locations
- Cold Spring Harbor Symposia on Quantitative Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, cell immortalization, cancer, tumor growth control, proto-oncogenes, tumor suppressor, signal transduction, cell cycle regulation, apoptosis, genetic stability
- MeSH terms
- Antineoplastic Agents, Cell Transformation, Neoplastic, DNA Replication, Enzyme Inhibitors, Female, Humans, Male, Models, Biological, Neoplasms, Phenotype, Cellular Senescence, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review